Extended Data Fig. 4: IgG isotype profile following 4-5 doses of AADvac1. | Nature Aging

Extended Data Fig. 4: IgG isotype profile following 4-5 doses of AADvac1.

From: ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer’s disease

Extended Data Fig. 4

Immunization with AADvac1 predominantly stimulates production antibodies of IgG1 isotype. Values were obtained after 4-5 doses of AADvac1 (n = 13, randomly selected). Thick vertical lines and error bars indicate geometric mean and 95% CI. Boxes indicate median and quartiles. Whiskers indicate 1.5× IQR.

Source data

Back to article page